DCAT Value Chain Insights

Debate on Drug Pricing Reforms Takes a New Turn

Congress is debating several proposed legislative measures on drug pricing. A key point of debate is what role should global pricing have in setting drug pricing in the US. What is on the table, and...

HPAPI Mfg: The Market Drivers and CDMO/CMO Expansions

High-potency active pharmaceutical ingredient (HPAPI) manufacturing continues to be an active area of investment by CDMOs/CMOs. DCAT Value Chain Insights analyzes key market drivers, including for...

SPONSORED CONTENT

Applications of Liquid-Filled Capsules for Challenging APIs in Pharmaceutical Manufacturing

Information
October 13, 2021
Sponsored by Altasciences

Liquid-filled capsules offer significant benefits for active pharmaceutical ingredients (APIs) presenting formulation or manufacturing challenges. Their use is beneficial throughout the different...

Read More
Monoclonal Antibody Manufacturing for BioPharma: To Build or Outsource?

Information
September 8, 2021
Sponsored by Samsung Biologics

As the global biologics market continues to grow, securing speed with scale has never been a greater priority. Here we demonstrate important factors to consider in making optimal outsourcing...

Read More
Feeling Pressure To Shorten Early Development Timelines?

Information
August 11, 2021
Sponsored by Thermo Fisher Scientific

Lengthy early-development timelines are common across new and emerging biotech companies for a multitude of reasons. Striking the right balance of speed, quality, risk, and investment allows you to...

Read More